Cargando…
Development of a hydroxamamide-based bifunctional chelating agent to prepare technetium-99m-labeled bivalent ligand probes
Hydroxamamide (Ham) is a thiol-free chelating agent that forms technetium-99m ((99m)Tc)-complexes with a metal-to-ligand ratio of 1:2 under moderate reaction conditions. Therefore, Ham-based chelating agents will produce (99m)Tc-labeled compounds with a bivalent targeting scaffold. For their univers...
Autores principales: | Shimizu, Yoichi, Ando, Masato, Iikuni, Shimpei, Watanabe, Hiroyuki, Ono, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455562/ https://www.ncbi.nlm.nih.gov/pubmed/34548586 http://dx.doi.org/10.1038/s41598-021-98235-x |
Ejemplares similares
-
Imaging of Cerebral Amyloid Angiopathy with Bivalent (99m)Tc-Hydroxamamide Complexes
por: Iikuni, Shimpei, et al.
Publicado: (2016) -
Novel Bivalent (99m)Tc-Complex with N-Methyl-Substituted Hydroxamamide as Probe for Imaging of Cerebral Amyloid Angiopathy
por: Iikuni, Shimpei, et al.
Publicado: (2016) -
Development of Technetium-99m-Labeled BODIPY-Based Probes Targeting Lipid Droplets Toward the Diagnosis of Hyperlipidemia-Related Diseases
por: Shimizu, Yoichi, et al.
Publicado: (2019) -
PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide
por: Iikuni, Shimpei, et al.
Publicado: (2020) -
The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist
por: Abiraj, Keelara, et al.
Publicado: (2018)